Fast Facts: Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is the most diagnosed leukemia in the Western world, accounting for approximately 25% of all new leukemia diagnoses. In recent years, remarkable progress has been made in our understanding of both the pathophysiology and genetics of CLL. While the disease generally affects older adults and initially follows an indolent course, cytogenetic and molecular profiling have helped to predict clinical outcomes. Greater prognostication, alongside the development of an increasing armamentarium of novel targeted therapies, has enabled us to provide more personalized management options for patients.
1140995975
Fast Facts: Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is the most diagnosed leukemia in the Western world, accounting for approximately 25% of all new leukemia diagnoses. In recent years, remarkable progress has been made in our understanding of both the pathophysiology and genetics of CLL. While the disease generally affects older adults and initially follows an indolent course, cytogenetic and molecular profiling have helped to predict clinical outcomes. Greater prognostication, alongside the development of an increasing armamentarium of novel targeted therapies, has enabled us to provide more personalized management options for patients.
0.0 In Stock
Fast Facts: Chronic Lymphocytic Leukemia

Fast Facts: Chronic Lymphocytic Leukemia

Fast Facts: Chronic Lymphocytic Leukemia

Fast Facts: Chronic Lymphocytic Leukemia

eBook2nd edition (2nd edition)

FREE

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

Chronic lymphocytic leukemia (CLL) is the most diagnosed leukemia in the Western world, accounting for approximately 25% of all new leukemia diagnoses. In recent years, remarkable progress has been made in our understanding of both the pathophysiology and genetics of CLL. While the disease generally affects older adults and initially follows an indolent course, cytogenetic and molecular profiling have helped to predict clinical outcomes. Greater prognostication, alongside the development of an increasing armamentarium of novel targeted therapies, has enabled us to provide more personalized management options for patients.

Product Details

ISBN-13: 9783318072303
Publisher: Karger, S. Inc.
Publication date: 06/07/2023
Sold by: Barnes & Noble
Format: eBook
Pages: 80
File size: 4 MB
From the B&N Reads Blog

Customer Reviews